IMU Biosciences
Profiles the human immune system at scale using multi-omic analysis and machine learning to transform disease diagnosis and treatment
$53MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Profiles the human immune system at scale using multi-omic analysis and machine learning to transform disease diagnosis and treatment
Uses quantum physics simulation and AI to engineer high-performance enzymes for pharma and industrial markets
Pitching IQ Capital? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room